Cisplatin-induced cardiotoxicity: Mechanisms and cardioprotective strategies

European Journal of Pharmacology

Volumn 650, Issue 1, 2011, Pages 335-341

  El Awady, El Sayed E ^a   Moustafa, Yasser M ^a   Abo Elmatty, Dina M ^a   Radwan, Asmaa ^a  

^a Suez Canal University   (Egypt)

Author keywords

Acetyl l carnitine; Apoptosis; Cisplatin induced cardiotoxicity; DL lipoic acid; Mitochondrial DNA; Silymarin

Indexed keywords

CELL NUCLEUS DNA; CISPLATIN; CISPLATINE; CREATINE KINASE; CREATINE KINASE MB; GLUTATHIONE; LACTATE DEHYDROGENASE; LEVACECARNINE; MALONALDEHYDE; MITOCHONDRIAL DNA; SILYMARIN; SODIUM CHLORIDE; SUPEROXIDE DISMUTASE; THIOCTIC ACID; TROPONIN I; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CARDIOTOXICITY; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; DNA DAMAGE; ENZYME ACTIVITY; HEART MUSCLE INJURY; HEART PROTECTION; LACTATE DEHYDROGENASE BLOOD LEVEL; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN CONTENT; RAT; SINGLE DRUG DOSE; TISSUE LEVEL; TREATMENT DURATION;

ACETYLCARNITINE; ANIMALS; ANTIOXIDANTS; BIOLOGICAL MARKERS; CARDIOTONIC AGENTS; CARDIOTOXINS; CELL NUCLEUS; CISPLATIN; DNA FRAGMENTATION; DNA, MITOCHONDRIAL; GLUTATHIONE; HEART; LIPID PEROXIDATION; MALE; OXIDATIVE STRESS; RATS; SILYMARIN; SUPEROXIDE DISMUTASE; THIOCTIC ACID;

EID: 78649745604     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2010.09.085     Document Type: Article

References (71)

1. A.R. Abu Ghadeer, S.E. Ali, S.A. Osman, F.A. Abu Bedair, M.M. Abbady, and M.R. El-Kady Antagonistic role of silymarin against cardiotoxicity and impaired antioxidation induced by adriamycin and/or radiation exposure in albino rats Pakistan J. Biol. Sci. 4 2001 604 607
2. T.A. Ajith, S. Usha, and V. Nivitha Ascorbic acid and a-tocopherol protect anticancer drug cisplatin-induced nephrotoxicity in mice. A comparative study Clin. Chim. Acta 375 2007 82 86
3. B.H. Ali, and M.S. Al Moundhri Agents ameliorating or augmenting the nephrotoxicity of cisplatin and other platinum compounds: a review of some recent research Food Chem. Toxicol. 44 2006 1173 1183
4. A.A. Al-Majed, M.M. Sayed-Ahmed, A.A. Al-Yahya, M.A. Aleisa, S.S. Al-Rejaie, and O.A. Al-Shabanah Propionyl-l-carnitine prevents the progression of cisplatin-induced cardiomyopathy in a carnitine-depleted rat model Pharmacol. Res. 53 2006 278 286
5. L.M.G. Antunes, J.D.C. Darin, and M.L.P. Bianchi Protective effects of Vitamin C against cisplatin-induced nephrotoxicity and lipid peroxidation in adult rats: a dose-dependent study Pharmacol. Res. 41 2000 405 411
6. I. Arany, and R.L. Safirstein Cisplatin nephrotoxicity Semin. Nephrol. 23 2003 460 464
7. O.A. Badary, S. Abdel-Maksoud, W.A. Ahmed, and G.H. Owieda Naringenin attenuates cisplatin nephrotoxicity in rats Life Sci. 76 2004 2125 2135
8. S.N. Buhl, and K.Y. Jackson Optimal conditions and comparison of lactate dehydrogenase catalysis of the lactate-to-pyruvate and pyruvate-to-lactate reactions in human serum at 25, 30, and 37 degrees C Clin. Chem. 24 1978 828 831
9. R.M. Cardinaal, J.C. De Groot, E.H. Huizing, G.F. Smoorenburg, and J.E. Veldman Ultrastructural changes in the albino guinea pig cochlea at different survival times following cessation of 8-day cisplatin administration Acta Otolaryngol. 124 2004 144 154
10. B.J. Chang, M. Nishikawa, E. Sato, K. Utsumi, and M. Inoue l-Carnitine inhibits cisplatin-induced injury of the kidney and small intestine Arch. Biochem. Biophys. 405 2002 55 64
11. Chappel, J.B., Hansford, R.G., 1969. Subcellular Components, Second Edition ed. Butterworths, London.
12. K.M. Cheriparambil, H. Vasireddy, A. Kuruvilla, B. Gambarin, M. Makan, and B.I. Saui Acute reversible cardiomyopathy and thromboembolism after cisplatin and 5-fluorouracil chemotherapy, a case report Angiology 51 2000 873 878
13. S. Chlopcikova, J. Psotova, P. Miketova, and V. Simanek Chemoprotective effect of plant phenolics against anthracycline-induced toxicity on rat cardiomyocytes. Part I. Silymarin and its flavonolignans Phytother. Res. 18 2004 107 110 (Pubitemid 38380601)
14. G. Chvetzoff, B. Bonotte, and B. Chauffert Anticancer chemotherapy. Prevention of toxicity Presse Méd. 27 1998 2106 2112
15. K.A. Conklin, and G.L. Nicolson Molecular replacement in cancer therapy: reversing cancer metabolic and mitochondrial dysfunction, fatigue and the adverse effects of cancer therapy Curr. Cancer Ther. Rev. 4 2008 66 76
16. T.L. Cornelison, and E. Reed Nephrotoxicity and hydration management for cisplatin, carboplatin, and ormaplatin Gynecol. Oncol. 50 1993 147 158
17. B.S. De martinis, and M. Bianchi Effect of vitamin C supplementation against cisplatin-induced toxicity and oxidative DNA damage in rats Pharmacol. Res. 44 2001 317 320
18. P. Devarajan, M. Savoca, and M. Castaneda Cisplatin-induced apoptosis in auditory cells: role of death receptor and mitochondrial pathways Hear. Res. 174 2002 45 54
19. T.P. Devasagayam, M. Subramanian, D.S. Pradhan, and H. Sies Prevention of singlet oxygen-induced DNA damage by lipoate Chem. Biol. Interact. 86 1993 79 92 (Pubitemid 23040436)
20. G.L. Ellman Tissue sulfhydryl groups Arch. Biochem. Biophys. 74 1959 214 226
21. W. Jones, X. Li, Z. Qu, L. Perriott, R.R. Whiteshell, and J.M. May Uptake, recycling, and antioxidant actions of α-lipoic acid in endothelial cells Free Radical Biol. Med. 33 2002 83 93
22. A. Kart, Y. Cigremi, M. Karaman, and H. Ozen Caffeic acid phenethyl ester (CAPE) ameliorates cisplatin-induced hepatotoxicity in rabbit Exp. Toxicol. Pathol. 62 1 2010 45 52
23. M. Kartalou, and J.M. Essigmann Mechanisms of resistance to cisplatin Mutat. Res. 478 2001 23 43
24. K. Karthikeyan, B.R. Sarala-Bai, and S. Niranjali-Devaraj Cardioprotective effect of grape seed proanthocyanidins on isoproterenol-induced myocardial injury in rats Int. J. Cardiol. 115 2007 326 333
25. J.S. Kim, L. He, and J.J. Lemasters Mitochondrial permeability transition: a common pathway to necrosis and apoptosis Biochem. Biophys. Res. Commun. 304 2003 463 470
26. P.E. Kintzel Anticancer drug-induced kidney disorders Drug Saf. 24 2001 19 38
27. I. Kocer, S. Taysi, M.V. Ertekin, I. Karslioglu, A. Gepdiremen, O. Sezen, and K. Serifoglu The effect of l-carnitine in the prevention of ionizing radiation-induced cataracts: a rat model Graefe's Arch. Clin. Exp. Ophthalmol. 245 2007 588 594
28. G. Kroemer, and J.C. Reed Mitochondrial control of cell death Nat. Med. 6 2000 513 519
29. H. Loster, and U. Bohm l-carnitine reduces malondialdehyde concentrations in isolated rat hearts in dependence on perfusion conditions Mol. Cell. Biochem. 217 2001 83 90
30. S.L. Marklund Pyrogallol autooxidation R.A. Greenwald, Handbook of Methods for Oxygen Radical Research 1985 CRC Press Boca Raton, Florida 243 247
31. P. Morazzoni, and E. Bombardelli Silybum marianum (Carduus marianus) Fitoterapia 66 1995 3 42
32. S. Moretti, G. Famularo, S. Marcellini, A. Boschini, G. Santini, V. Trinchieri, L. Lucci, E. Alesse, and C. De Simone l-carnitine reduces lymphocyte apoptosis and oxidant stress in HIV-1-infected subjects treated with zidovudine and didanosine Antioxid. Redox Signal. 4 2002 391 403
33. V.B. Pai, and M.C. Nahata Cardiotoxicity of chemotherapeutic agents: incidence, treatment and prevention Drug Saf. 22 2000 263 302
34. M.S. Park, M. De Leon, and P. Devarajan Cisplatin induces apoptosis in LLC-PK1 cells via activation of mitochondrial pathways J. Am. Soc. Nephrol. 13 2002 858 865
35. L.M. Pasetto, M.R. D'Andrea, and A.A. Brandes The development of platinum compounds and their possible combination Crit. Rev. Oncol. Hematol. 60 2006 59 75
36. A. Pietrangelo, F. Borella, G. Casalgrandi, G. Montosi, D. Ceccarelli, and D. Gallesi Antioxidant activity of silybin in vivo during long-term iron overload in rats Gastroenterology 109 1995 1941 1949
37. V. Pinzani, F. Bressolle, I.J. Haug, M. Galtier, J.P. Blayac, and P. Balmès Cisplatin-induced renal toxicity and toxicity-modulating strategies: a review Cancer Chemother. Pharmacol. 35 1994 1 9
38. H. Preuss, S. Jarrel, R. Scheckenobach, S. Lieberman, and R. Anderson Comparative effects of chromium vanadium and Gymnema sylvestre on sugar-induced blood pressure elevations in SHR J. Am. Coll. Nutr. 17 1998 116 123
39. J. Psotova, S. Chlopcikova, F. Grambal, V. Simanek, and J. Ulrichova Influence of silymarin and its flavonolignans on doxorubiciniron induced lipid peroxidation in rat heart microsomes and mitochondria in comparison with quercetin Phytother. Res. 16 2002 S63 S67
40. W. Qian, M. Nishikawa, A.M. Haque, M. Hirose, M. Mashimo, E. Sato, and M. Inoue Mitochondrial density determines the cellular sensitivity to cisplatin-induced cell death Am. J. Physiol. Cell Physiol. 289 2005 C1466 C1475
41. C.A. Rabik, and M.E. Dolan Molecular mechanisms of resistance and toxicity associated with platinating agents Cancer Treat. Rev. 33 2007 9 23
42. W. Ramadan The protective effect of α-lipoic acid in doxorubicin induced cardiotoxicity in rats 2008 Department of Biology Baylor University 74 pp.
43. L. Ramadan, H.M. Roushdy, G.M. Abu Senna, N.E. Amin, and O.A. El-Deshw Radioprotective effect of silymarin against radiation induced hepatotoxicity Pharmacol. Res. 45 2002 447 452
44. P.R. Rao, and R.K. Viswanath Cardioprotective activity of silymarin in ischemia-reperfusion-induced myocardial infarction in albino rats Exp. Clin. Cardiol. 12 2007 179 187
45. R. Renu Bist, and D.K. Bhatt The evaluation of effect of alpha-lipoic acid and vitamin E on the lipid peroxidation, gamma-amino butyric acid and serotonin level in the brain of mice (Mus musculus) acutely intoxicated with lindane J. Neurol. Sci. 276 2009 99 102
46. J. Sambrook, T. Maniatis, and F.F. Fritsch Molecular Cloning, A Laboratory Manual 3rd ed. 2001 Cold Spring Harbor Laboratory Press Cold Spring Harbor, New York
47. M. Satoh, N. Kashihara, S. Fujimoto, H. Horike, T. Tokura, T. Namikoshi, T. Sasaki, and H. Makino A novel free radical scavenger, edarabone, protects against cisplatin-induced acute renal damage in vitro and in vivo J. Pharmacol. Exp. Ther. 305 2003 1183 1190
48. S. Savitha, and C. Panneerselvam Carnitine and lipoic acid alleviates protein oxidation in heart mitochondria during aging process Biogerontology 7 2006 101 109
49. R.C. Scarpulla Nuclear activators and coactivators in mammalian mitochondrial biogenesis Biochim. Biophys. Acta 1576 2002 1 14
50. L.A. Schneide, J. Dissemond, P. Brenneisen, A. Hainzl, K. Briviba, and M. Wlaschek Adaptive cellular protection against UVA-1-induced lipid peroxidation in human dermal fibroblasts shows donor-to-donor variability and is glutathione dependent Arch. Dermatol. Res. 297 2006 324 328
51. S. Shanmugasundaram, R. Bharathithasan, and S. Elangovan 5-fluorouracil induced cardiotoxicity Indian Heart J. 54 2002 86 97
52. K.P. Shay, R.F. Moreau, E.J. Smith, and T.M. Hagen Is α-lipoic acid a scavenger of reactive oxygen species in vivo? Evidence for its initiation of stress signaling pathways that promote endogenous antioxidant capacity Life 60 2008 362 367
53. Y. Shemida, Y. Hirotani, Y.S. Akimoto, K. Ahindou, Y. Ijiri, T. Nishihori, and K. Tanaka Protective effects of capsaicin against cisplatin-induced nephrotoxicity in 686 rats Biol. Pharm. Bull. 28 2005 1635 1638
54. G. Szasz Proceedings of the Second International Symposium on Clinical Enzymology 1975 Chicago, IL, USA
55. J. Tamilselvan, G. Jayaraman, K. Sivarajan, and C. Panneerselvam Age-dependent upregulation of p53 and cytochrome c release and susceptibility to apoptosis in skeletal muscle fiber of aged rats: role of carnitine and lipoic acid Free Radic. Biol. Med. 43 2007 1656 1669
56. A. Vanella, A. Russo, R. Acquaviva, A. Campisi, C. Di Giacomo, V. Sorrenti, and M.L. Barcellona L-propionylcarnitine as superoxide scavenger, antioxidant, and DNA cleavage protector Cell Biol. Toxicol. 16 2000 99 104
57. G.A. Vogler Anesthesia and analgesia M.A. Suckow, S.H. Weisbroth, C.L. Franklin, The Laboratory Rat 2006 Elsevier Academic Press New York, USA 627 695
58. D. Wang, and S.J. Lippard Cellular processing of platinum anticancer drugs Nat. Rev. Drug Discov. 4 2005 307 320
59. N.I. Weijl, G.D. Hopman, A. Wipkink-Bakker, E.G. Lentjes, H.M. Berger, F.J. Cleton, and S. Osanto Cisplatin combination chemotherapy induces a fall in plasma antioxidants of cancer patients Ann. Oncol. 9 1998 1331 1337
60. M.R. Wieckowski, D. Brdiczka, and L. Wojtczak Long-chain fatty acids promote opening of the reconstituted mitochondrial permeability transition pore FEBS Lett. 484 2000 61 64
61. H. Wisemann Dietary influences on membrane function: importance in protection against oxidative damage and disease J. Nutr. Biochem. 7 1996 2 5
62. K. Wozniak, A. Czechowska, and J. Blasiak Cisplatin-evoked DNA fragmentation in normal and cancer cells and its modulation by free radical scavengers and the tyrosine kinase inhibitor STI571 Chem.-Biol. Interact. 147 2004 309 318
63. U. Würzburg, N. Hennrich, and H. Lang Bestimmung der Aktivität von Creatinkinase MB in Serum unter verwendung inhibierender Antikörper Klin. Wochenschr. 54 1976 357
64. M. Yagmurca, E. Fadillioglu, H. Erdogan, M. Ucar, S. Sogut, and M.K. Irmak Erdosteine prevents doxorubicin-induced cardiotoxicity in rats Pharmacol. Res. 48 2003 377 382
65. M. Yagmurca, O. Bas, H. Mollaoglu, O. Sahin, A. Nacar, O. Karaman, and A. Songurb Protective effects of erdosteine on doxorubicin-induced hepatotoxicity in rats Arch. Med. Res. 38 2007 380 385
66. J. Yanez, X. Teng, K. Roupe, M. Fariss, and N. Davies Chemotherapy induced gastrointestinal toxicity in rats: involvement of mitochondrial DNA, gastrointestinal permeability, and cyclooxygenase-2 J. Pharm. Pharm. Sci. 6 2003 308 314
67. Z. Yang, L.M. Schumaker, M.J. Egorin, E.G. Zuhowski, Z. Guo, and K.J. Cullen Cisplatin preferentially binds mitochondrial DNA and voltage-dependent anion channel protein in the mitochondrial membrane of head and neck squamous cell carcinoma: possible role in apoptosis Clin. Cancer Res. 12 2006 5817 5825
68. M.I. Yousef, A.A. Saad, and L.K. El-Shennawy Protective effect of grape seed proanthocyanidin extract against oxidative stress induced by cisplatin in rats Food Chem. Toxicol. 47 2009 1176 1183
69. D.D. Zhang, S.C. Lo, J.V. Cross, D.J. Templeton, and M. Hannink Keap1 is a redox-regulated substrate adaptor protein for a Cul3-dependent ubiquitin ligase complex Mol. Cell. Biol. 24 2004 10941 10953
70. B. Zhou, L. Wu, S. Tashiro, S. Onodera, F. Uchiumi, and T. Ikejima Silibinin protects rat cardiac myocyte from isoproterenol-induced DNA damage independent on regulation of cell cycle Biol. Pharm. Bull. 29 2006 1900 1905
71. B. Zhou, L.J. Wu, L.H. Li, S.I. Tashiro, S. Onodera, F. Uchiumi, and T. Ikejima Silibinin protects against isoproterenol-induced rat cardiac myocyte injury through mitochondrial pathway after up-regulation of SIRT-1 J. Pharmacol. Sci. 102 2006 387 395